These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2730023)

  • 21. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.
    Liotta LA; Goldfarb RH; Brundage R; Siegal GP; Terranova V; Garbisa S
    Cancer Res; 1981 Nov; 41(11 Pt 1):4629-36. PubMed ID: 6458354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.
    Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ
    Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence of components of fibrinolytic pathways in situ in laryngeal cancer.
    Wojtukiewicz MZ; Sierko E; Zacharski LR; Rózanska-Kudelska M; Zimnoch L
    Semin Thromb Hemost; 2003 Jun; 29(3):317-20. PubMed ID: 12888936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metastasis of human colon tumor cells in vivo: correlation with the overexpression of plasminogen activators and 72 kDa gelatinase.
    Shah V; Kumar S; Zirvi KA
    In Vivo; 1994; 8(3):321-6. PubMed ID: 7803712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The fibrinolytic system in experimental prostate tumor.
    Al-Mondhiry H; Drago J; Bartholomew MJ
    Thromb Haemost; 1986 Oct; 56(2):133-6. PubMed ID: 3810552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathways of coagulation/fibrinolysis activation in malignancy.
    Zacharski LR; Wojtukiewicz MZ; Costantini V; Ornstein DL; Memoli VA
    Semin Thromb Hemost; 1992 Jan; 18(1):104-16. PubMed ID: 1574711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of laminin in the attachment and metastasis of murine tumor cells.
    Terranova VP; Liotta LA; Russo RG; Martin GR
    Cancer Res; 1982 Jun; 42(6):2265-9. PubMed ID: 7074609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
    Krüger A; Soeltl R; Lutz V; Wilhelm OG; Magdolen V; Rojo EE; Hantzopoulos PA; Graeff H; Gänsbacher B; Schmitt M
    Cancer Gene Ther; 2000 Feb; 7(2):292-9. PubMed ID: 10770639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of primary cutaneous melanocytic neoplasms in urokinase-type plasminogen activator (uPA)-deficient and wild-type mice: cellular blue nevi invade but do not progress to malignant melanoma in uPA-deficient animals.
    Shapiro RL; Duquette JG; Roses DF; Nunes I; Harris MN; Kamino H; Wilson EL; Rifkin DB
    Cancer Res; 1996 Aug; 56(15):3597-604. PubMed ID: 8758932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The fibrinolytic system and its activators].
    Seifried E
    Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy.
    Schmitt M; Harbeck N; Thomssen C; Wilhelm O; Magdolen V; Reuning U; Ulm K; Höfler H; Jänicke F; Graeff H
    Thromb Haemost; 1997 Jul; 78(1):285-96. PubMed ID: 9198168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis.
    Choong PF; Nadesapillai AP
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S46-58. PubMed ID: 14600592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of plasminogen activators in cancer dissemination. Clinical perspectives].
    Alonso DF; Bal de Kier Joffé E
    Medicina (B Aires); 1992; 52(3):252-6. PubMed ID: 1342692
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
    J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of proteolytic enzymes in skin neoplasm progression and development of metastasis].
    Kozłowski L; Wojtukiewicz MZ
    Postepy Hig Med Dosw; 1999; 53(6):841-54. PubMed ID: 10737043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.